Equity crowdfunding appears immune to market volatility, on track for its best year yet

Social

Equity crowdfunding — or community raises, as the fundraising platforms involved prefer to call it — has grown steadily over the last few years. Regulations governing the process continue to evolve in the market’s favor, and 2022’s venture funding pullback may be the final piece needed to quiet the fundraising strategy’s naysayers for good.

This year looks poised to be monumental for equity crowdfunding, which entails raising capital through specific filings with the U.S. Securities and Exchange Commission, including Reg CF and Reg A, from a mix of investors that don’t have to be accredited.

Over the past few years, equity crowdfunding has shed much of the stigma that used to imply that only companies that weren’t good enough for VC raised this way. Some traditional VCs have even scouted on the platforms or encouraged their portfolio companies to pursue the process. But with the fundraising climate now showing cloudy skies, equity crowdfunding is getting ready for a field day.


TechCrunch+ is having an Independence Day sale! Save 50% on an annual subscription here. (More on TechCrunch+ here if you need it!)


More than $215 million was invested in startups on equity crowdfunding platforms this year through the end of May, according to the Arora Project, a Republic-owned platform that curates crowdfunding initiatives and tracks data, up from around $200 million in the same period last year. Crowdfunding campaigns raised a total of $502 million in 2021.

While that isn’t too big of a leap, industry players are encouraged by the growth and see scope for more improvement later in the year, as crowdfunding typically sees an uptick around the fourth quarter.

Products You May Like

Articles You May Like

Chroma, backed by Pinterest and Twitter co-founders, sells to AI audio company Bronze
Moonvalley wants to build more ethical video models
Tesla says it has reached a ‘conditional’ settlement in Rivian trade secrets lawsuit
OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI
Federal prosecutors have charged another Forbes 30 Under 30 alum with fraud

Leave a Reply

Your email address will not be published. Required fields are marked *